Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma

Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma

US Patent 8012697 · Granted Sep 6, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of effecting neuroprotection using soluble neuregulin isoforms2025
Method of effecting neuroprotection using soluble neuregulin isoforms2020
Method of effecting neuroprotection using soluble Neuregulin isoforms2019
Use of neuregulin-β as an indicator and/or target2013
Muscarinic antagonists with parp and sir modulating activity as cytoprotective a2013
Annexin A3 for cancer diagnosis2013
Autoimmune regulation of prostate cancer by annexin A32013
Muscarinic antagonists with PARP and SIR modulating activity as agents for infla2011
Use of finasteride, dutasteride and related compounds for the prevention or trea2011
Neuregulin-β isoform2011
Neuregulin-β isoforms associated with neuronal processes2010
Use of substances for treating tumors2010